Delivery Order SPE2DB22D3004-SPE2DB25FRU91
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 5 mg/0.5 ml pens valued at $1,553.39. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $12,539.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on July 31, 2025. This firm fixed-price, competitively awarded delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $31,043.40 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 8, 2025. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability...
- On July 24, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $7,569.60 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a non-competitive award executed under an existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections with a ceiling value of $5,064.15. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is set to conclude by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $23,423.40 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $6,921.52 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract, designated as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens with a ceiling value of $8,756.28. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $5,529.77 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and has an ultimate completion date of August 6, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $19,842.55 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 4, 2025, with completion targeted for August 5, 2025. The contract utilized firm fixed-price pricing with no set-aside designation, indicating competitive award through open procurement. Performance will be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRU91Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,338.06 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 5, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical devices to support military and veteran healthcare systems. The Zepbound procurement demonstrates the company's role in providing specialized pharmaceutical products across multiple therapeutic domains to Defense Health Agency customers and other federal healthcare entities. This delivery order represents a routine transactional fulfillment under the broader pharmaceutical prime vendor arrangement that enables flexible medical supply support to defense and civilian government healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 8/4/25 |